The expectations for the reduction of drug prices by stakeholders in the pharmaceutical sector have been dashed following the delays in the implementation of the executive order on healthcare products issued by President Bola Tinubu earlier this year. Despite the promise of lower production costs for local manufacturers through tax exemptions and tariff removals, stakeholders
Read More